Live Markets
GSPC
7,428.78
+0.21%
IXIC
24,876.91
−0.22%
RUT
2,953.80
+0.20%
FTSE
10,902.30
+0.29%
GDAXI
25,532.87
+0.27%
FCHI
8,417.67
−0.49%
STOXX50E
6,271.53
−0.29%
XLE
58.54
+1.72%
XLF
57.63
+0.07%
GSPC
7,428.78
+0.21%
IXIC
24,876.91
−0.22%
RUT
2,953.80
+0.20%
FTSE
10,902.30
+0.29%
GDAXI
25,532.87
+0.27%
FCHI
8,417.67
−0.49%
STOXX50E
6,271.53
−0.29%
XLE
58.54
+1.72%
XLF
57.63
+0.07%
Wednesday, July 29, 2026
·
George Town, KY
·
29°
·
Partly Cloudy
Markets Open · NYSE
·
Newsletter
·
Masthead
·
Sign In
VOL. XII · NO. 117
Established MMXIV · George Town, Grand Cayman
Atlantic Edition · $4.50
The
Cayman
Journal
Finance · Business · Technology · Caribbean & Global Affairs
⌕
Research
Markets
13F
Insiders
Press Releases
Companies
People
Real Estate
Yacht
AI Agents + MCP
Business
Economy
Markets & Finance
Research Reports
Technology
Insider · CIK 0001760648
OrbiMed Capital GP VII LLC
Follow
Positions
Keros Therapeutics, Inc.
·
KROS
(1 filing)
Passage BIO, Inc.
·
PASG
(5 filings)
MBX Biosciences, Inc.
·
MBX
(1 filing)
Recent Filings (2)
Apr 17, 2025
Form 4
Passage BIO, Inc.
-149,054 sh
Jan 8, 2025
Form 4
Passage BIO, Inc.
-147,024 sh